Endogen Inc Sample Contracts

AutoNDA by SimpleDocs
AMONG
Agreement and Plan of Merger • June 2nd, 1999 • Endogen Inc • In vitro & in vivo diagnostic substances • Massachusetts
ENDOGEN, INC.
Incentive Stock Option Agreement • June 2nd, 1999 • Endogen Inc • In vitro & in vivo diagnostic substances • Massachusetts
SUPPLY AGREEMENT ----------------
Supply Agreement • April 10th, 1998 • Endogen Inc • In vitro & in vivo diagnostic substances
June 2, 1999 To Our Stockholders: On behalf of the Board of Directors of Endogen, Inc., a Massachusetts corporation (the "COMPANY"), we are pleased to inform you that, on May 27, 1999, the Company entered into an Agreement and Plan of Merger (the...
Merger Agreement • June 2nd, 1999 • Endogen Inc • In vitro & in vivo diagnostic substances

On behalf of the Board of Directors of Endogen, Inc., a Massachusetts corporation (the "COMPANY"), we are pleased to inform you that, on May 27, 1999, the Company entered into an Agreement and Plan of Merger (the "MERGER AGREEMENT") with PerBio Science AB, a Swedish corporation ("PARENT") and EWOK Acquisition Corp., a Massachusetts corporation and a wholly-owned subsidiary of Parent ("PURCHASER"), pursuant to which Purchaser has today commenced a cash tender offer (the "OFFER") to purchase all of the outstanding shares (the "SHARES") of the Company's Common Stock at $3.75 per Share. Under the terms of the Merger Agreement, the Offer will be followed by a merger of Purchaser with and into the Company (the "MERGER") in which any Shares not tendered will be converted into the right to receive $3.75 per Share in cash, without interest.

1.0 DEFINITIONS
Agreement • August 28th, 1998 • Endogen Inc • In vitro & in vivo diagnostic substances • New Jersey
WITNESSETH
License Agreement • August 28th, 1998 • Endogen Inc • In vitro & in vivo diagnostic substances • California
RECITALS
Loan Modification Agreement • August 28th, 1998 • Endogen Inc • In vitro & in vivo diagnostic substances
RECITALS
Second Loan Modification Agreement • January 13th, 1998 • Endogen Inc • In vitro & in vivo diagnostic substances
RECITALS
Third Loan Modification Agreement • October 14th, 1998 • Endogen Inc • In vitro & in vivo diagnostic substances
RECITALS
Fourth Loan Modification Agreement • April 14th, 1999 • Endogen Inc • In vitro & in vivo diagnostic substances
Exhibit 4.2 ----------- ENDOGEN, INC.
Endogen Inc • July 13th, 1998 • In vitro & in vivo diagnostic substances • Massachusetts
ENDOGEN, INC.
Endogen Inc • January 13th, 1998 • In vitro & in vivo diagnostic substances

FOR VALUE RECEIVED, the undersigned, ENDOGEN, INC., a Massachusetts corporation (the "Borrower"), promises to pay to the order of Silicon Valley Bank, a California-chartered bank ("Bank"), at such place as the holder hereof may designate, in lawful money of the United States of America, the aggregate unpaid principal amount of all advances ("Advances") made by Bank to Borrower in accordance with the terms of the Loan and Security Agreement between Borrower and Bank dated August 31, 1997, as amended from time to time (the "Loan Agreement"), up to a maximum principal amount of TWO HUNDRED FIFTY THOUSAND AND NO/100THS Dollars ($250,000), until paid in full. Borrower shall also pay interest on the aggregate unpaid principal amount of such Advances at the rates and in accordance with the terms of the Loan Agreement. The entire principal amount and all accrued interest shall be due and payable on MARCH 27, 2001.

BETWEEN ENDOGEN, INC. AND
Product Development and Marketing Agreement • October 9th, 1997 • Endogen Inc • In vitro & in vivo diagnostic substances • Massachusetts
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!